small molecule

ACYCLOVIR

ACYCLOVIR

Loss of exclusivityloss of exclusivity
CompanySUN PHARMA CANADA INC

Drug detail

Brand nameACYCLOVIR
Active ingredientACYCLOVIR
Strength5%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalJune 2024
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ACYCLOVIR patent cliff — loss of exclusivity — | CliffBio